Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment

Kinase Inhibitor ◽

Anticancer Effects ◽

Inhibitor Treatment

Tepotinib. Selective MET receptor tyrosine kinase inhibitor, Treatment of lung and liver cancers

Drugs of the Future ◽

10.1358/dof.2016.041.11.2555984 ◽

2016 ◽

Vol 41 (11) ◽

pp. 659

Author(s):

M. Medová

Keyword(s):

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Met Receptor ◽

Met Receptor Tyrosine Kinase ◽

Liver Cancers ◽

Inhibitor Treatment

Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models

Cancer Science ◽

10.1111/j.1349-7006.2004.tb03187.x ◽

2004 ◽

Vol 95 (12) ◽

pp. 984-989 ◽

Cited By ~ 46

Author(s):

Fumiko Taguchi ◽

Yasuhiro Koh ◽

Fumiaki Koizumi ◽

Tomohide Tamura ◽

Nagahiro Saijo ◽

...

Keyword(s):

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Anticancer Effects ◽

Xenograft Models

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth

Delayed Therapy with Receptor Tyrosine Kinase Inhibitor Nintedanib Diminished Chronic Rejection in a Murine Lung Transplant Model

10.1055/s-0041-1725623 ◽

2021 ◽

Author(s):

J. Mauer ◽

A. Kuckhahn ◽

J. Distler ◽

B. Spriewald ◽

M. Ramsperger-Gleixner ◽

...

Keyword(s):

Tyrosine Kinase ◽

Chronic Rejection ◽

Lung Transplant ◽

Kinase Inhibitor ◽

Murine Lung ◽

Transplant Model

Everolimus zur Behandlung des metastasierten Nierenzellkarzinoms nach Versagen der ersten VEGFr-TKI(Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor)-Therapie: Ergebnisse einer Interimsanalyse einer nichtinterventionellen Studie

Karger Kompass Onkologie ◽

10.1159/000356898 ◽

2014 ◽

Vol 1 (1) ◽

pp. 28-29

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Glomerular Changes in Rats Administered ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor - Linking Ultrastructure to Mechanism

Microscopy and Microanalysis ◽

10.1017/s1431927609097566 ◽

2009 ◽

Vol 15 (S2) ◽

pp. 16-17

Author(s):

J Fagerland ◽

S Morgan

Keyword(s):

Tyrosine Kinase ◽

Receptor Tyrosine Kinase Inhibitor

Kinase Inhibitor ◽

Extended abstract of a paper presented at Microscopy and Microanalysis 2009 in Richmond, Virginia, USA, July 26 – July 30, 2009

The effect of combination treatment with gemcitabine and the EGFR-receptor tyrosine kinase inhibitor iressa with photodynamic therapy in bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(03)80175-6 ◽

2003 ◽

Vol 2 (1) ◽

pp. 44

Author(s):

C.H. Briggs ◽

C.D. Betts ◽

K.J. O'Flynn ◽

J.V. Moore ◽

N.W. Clarke

Keyword(s):

Bladder Cancer ◽

Photodynamic Therapy ◽

Tyrosine Kinase ◽

Combination Treatment ◽

Receptor Tyrosine Kinase Inhibitor

Kinase Inhibitor ◽

172 Preclinical profile of ABP309, a potent 2nd generation VEGF receptor tyrosine kinase inhibitor belonging to the class of aminonicotinamides

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80180-0 ◽

2004 ◽

Vol 2 (8) ◽

pp. 54-55

Author(s):

J. Brueggen ◽

G. Bold ◽

R. Cozens ◽

P.W. Manley ◽

J. Mestan ◽

...

Keyword(s):

Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

2Nd Generation

Receptor Tyrosine Kinase Inhibitor Profiling Using Bead-Based Multiplex Sandwich Immunoassays

Methods in Molecular Biology - Kinase Inhibitors ◽

10.1007/978-1-61779-337-0_13 ◽

2011 ◽

pp. 191-202 ◽

Cited By ~ 3

Author(s):

Oliver Pötz ◽

Nicole Schneiderhan-Marra ◽

Tanja Henzler ◽

Thomas Herget ◽

Thomas O. Joos

Keyword(s):

Tyrosine Kinase ◽

Receptor Tyrosine Kinase Inhibitor

Kinase Inhibitor ◽

2038 A Phase I/II Study of Oral Pazopanib, a Receptor Tyrosine Kinase Inhibitor, in Neovascular Age Related Macular Degeneration

SciVee ◽

10.4016/40519.01 ◽

2012 ◽

Author(s):

Jason Slakter

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Macular Degeneration ◽

Kinase Inhibitor ◽

Age Related Macular Degeneration ◽

Age Related